AbbVie
ABBV
#31
Rank
$300.88 B
Marketcap
$170.39
Share price
-1.01%
Change (1 day)
23.63%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Total assets

Total assets on the balance sheet as of March 2024 : $148.87 B

According to AbbVie's latest financial reports the company's total assets are $148.87 B. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

AbbVie - Total assets on balance sheet (from 2011 to 2024)

Total assets by year

Year Total assets Change
2023-12-31$134.71 B-2.95%
2022-12-31$138.80 B-5.27%
2021-12-31$146.52 B-2.68%
2020-12-31$150.56 B68.96%
2019-12-31$89.11 B50.15%
2018-12-31$59.35 B-16.15%
2017-12-31$70.78 B7.09%
2016-12-31$66.09 B24.6%
2015-12-31$53.05 B92.82%
2014-12-31$27.51 B-5.77%
2013-12-31$29.19 B8.11%
2012-12-31$27.00 B38.35%
2011-12-31$19.52 B-7.64%
2010-12-31$21.13 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
$221.09 B 48.51%๐Ÿ‡บ๐Ÿ‡ธ USA
$63.94 B-57.05%๐Ÿ‡บ๐Ÿ‡ธ USA
$92.98 B-37.54%๐Ÿ‡บ๐Ÿ‡ธ USA
$26.56 B-82.15%๐Ÿ‡บ๐Ÿ‡ธ USA
$56.29 B-62.19%๐Ÿ‡บ๐Ÿ‡ธ USA
$99.03 B-33.48%๐Ÿ‡บ๐Ÿ‡ธ USA
$102.29 B-31.29%๐Ÿ‡ฌ๐Ÿ‡ง UK
$73.94 B-50.33%๐Ÿ‡ฌ๐Ÿ‡ง UK
$3.47 B-97.67%๐Ÿ‡บ๐Ÿ‡ธ USA